Literature DB >> 8588480

Collagen, elastin and glycosaminoglycans in aortic aneurysms.

K Sobolewski1, M Wolańska, E Bańkowski, M Gacko, S Głowiński.   

Abstract

The walls of human abdominal aortas and atherosclerosis-induced aneurysms contain similar amounts of collagen. The quantitative ratio between collagens of various types of this protein does not differ significantly either, whereas solubility of the collagen in aneurysmal wall and its susceptibility to the action of EDTA are distinctly decreased. In contrast with collagen, the amount of elastin in aneurysms is significantly lower. Total amount of glycosaminoglycans slightly decreased as compared with that of normal tissue, but the ratio of particular compounds varies. The percentage of chondroitin sulphate is increased and that of heparan sulphate significantly decreased. The significance of these changes in pathogenesis of aneurysms is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8588480

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  4 in total

Review 1.  Possible mechanical roles of glycosaminoglycans in thoracic aortic dissection and associations with dysregulated transforming growth factor-β.

Authors:  J D Humphrey
Journal:  J Vasc Res       Date:  2012-09-25       Impact factor: 1.934

2.  Metalloproteinases, insulin-like growth factor-I and its binding proteins in aortic aneurysm.

Authors:  Bogusław Panek; Marek Gacko; Jerzy Pałka
Journal:  Int J Exp Pathol       Date:  2004-06       Impact factor: 1.925

Review 3.  Elastin and collagen fibre microstructure of the human aorta in ageing and disease: a review.

Authors:  Alkiviadis Tsamis; Jeffrey T Krawiec; David A Vorp
Journal:  J R Soc Interface       Date:  2013-03-27       Impact factor: 4.118

Review 4.  Intracranial and abdominal aortic aneurysms: similarities, differences, and need for a new class of computational models.

Authors:  J D Humphrey; C A Taylor
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.